AIM2 and age-related macular degeneration: AIM2 inflammasome activation has also been shown in diseases such as psoriasis [74,75,76], atherosclerotic lesions [77], or cardiovascular diseases [78] that have ocular manifestations or serve as risk factors for AMD.